Vaiarelli A

No ORCID on file · 7 papers in corpus
2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-026-03910-5

PurposeTo evaluate whether artificial endometrial preparation using hormone replacement therapy (HRT) influences clinical and neonatal outcomes compared with modified natural cycles (mNC) in single euploid vitrified-warmed blastocyst transf…

2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03722-z

PurposeTo identify treatment-related factors influencing low oocyte maturation rates in standard ovarian stimulation (OS) cycles and patients' candidates for clinical studies on rescue-IVM.MethodsRetrospective study including retrievals wit…

2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1854570

AimsTo evaluate DuoStim strategy across a decade from its clinical implementation in IVF by comparing embryological and clinical outcomes between the first and second ovarian stimulations (1st-OS and 2nd-OS) conducted within 30 days, focusi…

2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03396-7

PurposeTo evaluate the performance of different embryo transfer (ET) operators in a strictly controlled scenario minimizing potential confounders.MethodsThis single-center retrospective cohort study analyzed vitrified-warmed single euploid …

2025
Andrology ·doi:10.1111/andr.13811

ObjectiveTo examine the association between semen parameters, assessed according to World Health Organization (WHO)-2021 criteria, and paternal body mass index (BMI) and age, with embryological and clinical outcomes in ICSI cycles involving…

2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03379-0

PurposeObesity is increasingly at the center of modern international healthcare systems. This is a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) aimed at evaluating the impact of f…

2020
Therapeutic advances in reproductive health ·doi:10.1177/2633494120941480

Despite the considerate progress to which assisted reproduction technology (ART) has been subject since 1978, some issues remain unresolved. Notably, the clinical management of patients with a poor ovarian response is still a challenge in e…